Position in CAPR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,929,361
+$1,593,867 QoQ
Shares Held
80,123
+626.0% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 169 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAPR Over Time
Shares Held
Position Value (USD)
Derivatives in CAPR
reported options exposure · as of Jun 30, 2026CallValue
$758,520
CallShares
31,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. CAPR ranks #110 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in CAPR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $758,520 | 31,500 | Call | Defined | 2026-08-03 | |
| 2026-06-30 | $1,929,361 | 80,123 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $957,600 | 31,500 | Call | Defined | 2026-05-11 | |
| 2026-03-31 | $335,494 | 11,036 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $82,509 | 2,859 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $49,892 | 6,920 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $293,211 | 29,528 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $893,994 | 94,204 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $138,000 | 10,000 | Call | Defined | 2025-02-12 | |
| 2024-12-31 | $1,295,943 | 93,909 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $311,089 | 20,453 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $53,724 | 11,263 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $532,010 | 78,352 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $116,372 | 23,798 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $210,641 | 61,591 | Shares | Defined | 2023-12-06 | |
| 2022-03-31 | $68 | 20 | Shares | Defined | 2022-05-12 | |
| 2020-12-31 | $3,087 | 900 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,775 | 1,100 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,060 | 1,100 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||